aTyr Pharma | LIFE - Gross Profit On Sales


aTyr Pharma reported $190K in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Ardelyx USD 106.35M 23.51M Sep/2025
aTyr Pharma USD 190K 15.57M Sep/2025
Biogen USD 1.65B 34.6M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Cipla INR 41.64B 6.31B Dec/2025
Clal Biotechnology ILS -857K 1.42M Jun/2022
Compugen USD 241K 649K Sep/2025
CSL USD 1.75B 2.53B Jun/2025
Curis USD -7.72M 140K Jun/2024
Galapagos EUR -13.57M 74.82M Sep/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Grifols EUR 766.49M 39.74M Dec/2024
Novartis USD 10.82B 695M Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
United Therapeutics USD 315.5M 286.6M Dec/2025
Xoma 992K 846K Jun/2024